Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04889716
Title CAR-T Followed by Bispecific Antibodies
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Abramson Cancer Center of the University of Pennsylvania

B-cell lymphoma

primary mediastinal B-cell lymphoma

diffuse large B-cell lymphoma

follicular lymphoma


Obinutuzumab + RO7082859


Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.